Keith S Manchester - Net Worth and Insider Trading
Keith S Manchester Net Worth
The estimated net worth of Keith S Manchester is at least $15 Million dollars as of 2024-12-28. Keith S Manchester is the Director of Roivant Sciences Ltd and owns about 1,277,178 shares of Roivant Sciences Ltd (ROIV) stock worth over $15 Million. Keith S Manchester is also the Director of Arbutus Biopharma Corp and owns about 46,069 shares of Arbutus Biopharma Corp (ABUS) stock worth over $147,881. Details can be seen in Keith S Manchester's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Keith S Manchester has not made any transactions after 2024-09-25 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Keith S Manchester
Keith S Manchester Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Keith S Manchester owns 3 companies in total, including Arbutus Biopharma Corp (ABUS) , Myovant Sciences Ltd (MYOV) , and Roivant Sciences Ltd (ROIV) .
Click here to see the complete history of Keith S Manchester’s form 4 insider trades.
Insider Ownership Summary of Keith S Manchester
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ABUS | Arbutus Biopharma Corp | 2024-08-14 | director |
| MYOV | Myovant Sciences Ltd | 2016-10-26 | director |
| ROIV | Roivant Sciences Ltd | 2024-09-25 | director |
Keith S Manchester Latest Holdings Summary
Keith S Manchester currently owns a total of 2 stocks. Among these stocks, Keith S Manchester owns 1,277,178 shares of Roivant Sciences Ltd (ROIV) as of September 25, 2024, with a value of $15 Million and a weighting of 99.03%. Keith S Manchester also owns 46,069 shares of Arbutus Biopharma Corp (ABUS) as of August 14, 2024, with a value of $147,881 and a weighting of 0.97%.
Latest Holdings of Keith S Manchester
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ROIV | Roivant Sciences Ltd | 2024-09-25 | 1,277,178 | 11.80 | 15,070,700 |
| ABUS | Arbutus Biopharma Corp | 2024-08-14 | 46,069 | 3.21 | 147,881 |
Holding Weightings of Keith S Manchester
Keith S Manchester Form 4 Trading Tracker
According to the SEC Form 4 filings, Keith S Manchester has made a total of 3 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 503,000 shares on September 25, 2024, which brought Keith S Manchester around $6 Million.
According to the SEC Form 4 filings, Keith S Manchester has made a total of 1 transactions in Arbutus Biopharma Corp (ABUS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Arbutus Biopharma Corp is the sale of 8,846 shares on August 14, 2024, which brought Keith S Manchester around $32,642.
Insider Trading History of Keith S Manchester
- 1
Keith S Manchester Trading Performance
Keith S Manchester Ownership Network
Keith S Manchester Owned Company Details
What does Arbutus Biopharma Corp do?
Who are the key executives at Arbutus Biopharma Corp?
Keith S Manchester is the director of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .
Arbutus Biopharma Corp (ABUS) Insider Trades Summary
Over the past 18 months, Keith S Manchester made 1 insider transaction in Arbutus Biopharma Corp (ABUS) with a net sale of 8,846. Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .
In summary, during the past 3 months, insiders sold 0 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.
Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Arbutus Biopharma Corp Insider Transactions
Keith S Manchester Mailing Address
Above is the net worth, insider trading, and ownership report for Keith S Manchester. You might contact Keith S Manchester via mailing address: C/o Roivant Sciences Ltd., 11-12 St. James's Square Suite 1, 3rd Fl, London X0 Sw1y 4l.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
